Subscribe to our Email Alerts
Menu
Home
About Us
Company Overview
Company Values
Board of Directors
Executive Management
Corporate Directory
Products
DAYBUE™ (trofinetide)
Pipeline
Pipeline
Trofinetide
Rett Syndrome
NNZ-2591
Phelan-McDermid Syndrome
Angelman Syndrome
Pitt Hopkins Syndrome
Hypoxic-ischemic encephalopathy
Prader-Willi Syndrome
Science
Science Behind Neuren's Products
Trofinetide Published Studies & Presentations
Rett Syndrome
NNZ-2591Published Studies & Presentations
Phelan-McDermid Syndrome
Pitt Hopkins Syndrome
Angelman Syndrome
Investors
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
News & Media
Media
Contact
Contact Us
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Dashboard
Share Price Information
ASX Announcements
Annual and Interim Reports
Investor Presentations
Corporate Governance
Analyst Coverage
Shareholder Services
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
2019
2018
Older
Jul 06, 2020
Section 708A notice
Jul 06, 2020
Appendix 2A
Jul 01, 2020
Electing to receive SPP documents by e-mail
Jun 29, 2020
Results of Meeting
Jun 29, 2020
AGM Chairman's Address and CEO Presentation
Jun 29, 2020
Proposed issue of Securities - NEU
Jun 29, 2020
Neuren successfully completes $20m capital raising
Jun 25, 2020
Trading Halt
Jun 16, 2020
Temporary enrolment pause ended in Phase 3 trial in the US
Jun 02, 2020
Change of Director's Interest Notice
Previous
1
2
3
4
5
6
Next
